TITLE
Recommendation to adopt resolution authorizing City Manager, or designee, to execute a contract with Hologic, Inc., of San Diego, CA, for the purchase of molecular diagnostic test kits, in an annual amount not to exceed $250,000, for a period of one year, with the option to renew for two additional one-year periods, at the discretion of the City Manager. (Citywide)
DISCUSSION
City Council approval is requested to enter into a contract with Hologic, Inc. (Hologic), to purchase molecular tests for mycobacteria species and chlamydia/gonorrhea (CT/GC) identification. The Health and Human Services Department’s (Health Department) Public Health Laboratory performs approximately 18,500 chlamydia tests, 15,000 gonorrhea tests, and 200 DNA mycobacteria tests each year. In addition to Health Department’s Tuberculosis Clinic and STD-Family Planning Clinic, the laboratory also provides these tests to the following fee-for-service agencies: St. Mary’s Hospital, Long Beach Memorial Medical Center, the University of California, San Diego (UCSD), and the University of Southern California (USC). This partnership, with the different programs and agencies, makes up the public health laboratory system. With the Public Health Laboratory in the lead role, system participants play an interconnected role in facilitating the exchange of information that aids in the prevention and spread of infectious diseases and public health threats.
Hologic is the only company that has FDA approval on most of the specimen collection sites for testing for CT/GC. Additionally, Hologic’s APTIMA Combo2 Assay for CT/GC and mycobacteria DNA probe is proprietary to Hologic.
City Charter Section 1801 requires that contracts for City purchases be awarded to the lowest responsible bidder after a competitive bid process but allows for awards without a competitive bid process if accompanied by a Resolution adopted by the City Council.
This matter was reviewed by Deputy City Attorney Linda T. Vu...
Click here for full text